Latest papers

Metabolite profiling identifies markers of uremia.

Acute paralysis in a uremic patient.

Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy.

[Pharmacological and clinical profiles of nalfurafine hydrochloride (Remitch) capsules 2.5 microg) , a new therapeutic agent for the treatment of uremic pruritus in hemodialysis patients].

Topical capsaicin therapy for uremic pruritus in patients on hemodialysis.

Transplant-associated hyperglycemia: shedding light on the mechanisms.

New-onset diabetes mellitus after kidney transplantation in Denmark.

In vitro inhibition of low density lipoprotein carbamylation by vitamins, as an ameliorating atherosclerotic risk in uremic patients.

Amelioration of cisplatin-induced nephrotoxicity by extracts of Hemidesmus indicus and Acorus calamus.

HPLC study of uremic fluids related to optical dialysis adequacy monitoring.

Uremic toxicity of indoxyl sulfate.

Preventive effect of a proteasome inhibitor on the formation of accelerated atherosclerosis in rabbits with uremia.

Characterization of mandibular bone in a mouse model of chronic kidney disease.

Genetic predisposition to advanced glycation end products toxicity is related to prognosis of chronic hemodialysis patients.

[Clinical impact of hypercalcemia after kidney transplant].

Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.

Genomic damage in endothelial progenitor cells from uremic patients in hemodialysis.

[Treatment of uraemic anorexia with megestrol acetate].

[Electrophysiological diagnosis of severe carpal tunnel syndrome in patients on maintenance hemodialysis with created arterio-venous fistula and concomitant polyneuropathy].

Reduction of free immunoglobulin light chains using adsorption properties of hemodiafiltration with endogenous reinfusion.